Connection

Co-Authors

This is a "connection" page, showing publications co-authored by George Gao and Jianxun Qi.
Connection Strength

4.431
  1. A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS. Cell. 2020 08 06; 182(3):722-733.e11.
    View in: PubMed
    Score: 0.222
  2. Structures of the four Ig-like domain LILRB2 and the four-domain LILRB1 and HLA-G1 complex. Cell Mol Immunol. 2020 09; 17(9):966-975.
    View in: PubMed
    Score: 0.208
  3. Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab. Cell Rep. 2018 10 23; 25(4):909-920.e4.
    View in: PubMed
    Score: 0.198
  4. Crystal Structure of the Capsid Protein from Zika Virus. J Mol Biol. 2018 03 30; 430(7):948-962.
    View in: PubMed
    Score: 0.189
  5. Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab. Protein Cell. 2018 01; 9(1):135-139.
    View in: PubMed
    Score: 0.187
  6. Structures of human-infecting Thogotovirus fusogens support a common ancestor with insect baculovirus. Proc Natl Acad Sci U S A. 2017 10 17; 114(42):E8905-E8912.
    View in: PubMed
    Score: 0.184
  7. Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus. J Virol. 2017 09 15; 91(18).
    View in: PubMed
    Score: 0.183
  8. Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope. Proc Natl Acad Sci U S A. 2017 09 05; 114(36):E7564-E7573.
    View in: PubMed
    Score: 0.182
  9. Conserved Vd1 Binding Geometry in a Setting of Locus-Disparate pHLA Recognition by d/aß T Cell Receptors (TCRs): Insight into Recognition of HIV Peptides by TCRs. J Virol. 2017 Sep 01; 91(17).
    View in: PubMed
    Score: 0.182
  10. Avian-to-Human Receptor-Binding Adaptation by Influenza A Virus Hemagglutinin H4. Cell Rep. 2017 08 01; 20(5):1201-1214.
    View in: PubMed
    Score: 0.182
  11. Structural basis of nectin-1 recognition by pseudorabies virus glycoprotein D. PLoS Pathog. 2017 May; 13(5):e1006314.
    View in: PubMed
    Score: 0.179
  12. Remarkably similar CTLA-4 binding properties of therapeutic ipilimumab and tremelimumab antibodies. Oncotarget. 2017 Sep 15; 8(40):67129-67139.
    View in: PubMed
    Score: 0.179
  13. Structure of the S1 subunit C-terminal domain from bat-derived coronavirus HKU5 spike protein. Virology. 2017 07; 507:101-109.
    View in: PubMed
    Score: 0.178
  14. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun. 2017 04 10; 8:15092.
    View in: PubMed
    Score: 0.178
  15. The crystal structure of Zika virus NS5 reveals conserved drug targets. EMBO J. 2017 04 03; 36(7):919-933.
    View in: PubMed
    Score: 0.177
  16. Putative Receptor Binding Domain of Bat-Derived Coronavirus HKU9 Spike Protein: Evolution of Betacoronavirus Receptor Binding Motifs. Biochemistry. 2016 Nov 01; 55(43):5977-5988.
    View in: PubMed
    Score: 0.172
  17. Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26. Cell Host Microbe. 2014 Sep 10; 16(3):328-37.
    View in: PubMed
    Score: 0.149
  18. Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. J Virol. 2013 Dec; 87(24):13134-40.
    View in: PubMed
    Score: 0.139
  19. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature. 2013 Aug 08; 500(7461):227-31.
    View in: PubMed
    Score: 0.137
  20. The membrane protein of severe acute respiratory syndrome coronavirus acts as a dominant immunogen revealed by a clustering region of novel functionally and structurally defined cytotoxic T-lymphocyte epitopes. J Infect Dis. 2010 Oct 15; 202(8):1171-80.
    View in: PubMed
    Score: 0.114
  21. Novel immunodominant peptide presentation strategy: a featured HLA-A*2402-restricted cytotoxic T-lymphocyte epitope stabilized by intrachain hydrogen bonds from severe acute respiratory syndrome coronavirus nucleocapsid protein. J Virol. 2010 Nov; 84(22):11849-57.
    View in: PubMed
    Score: 0.113
  22. The molecular basis for SARS-CoV-2 binding to dog ACE2. Nat Commun. 2021 07 07; 12(1):4195.
    View in: PubMed
    Score: 0.060
  23. Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species. Cell. 2021 06 24; 184(13):3438-3451.e10.
    View in: PubMed
    Score: 0.059
  24. Structures of the SARS-CoV-2 nucleocapsid and their perspectives for drug design. EMBO J. 2020 10 15; 39(20):e105938.
    View in: PubMed
    Score: 0.056
  25. Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2. Cell Rep. 2020 06 16; 31(11):107774.
    View in: PubMed
    Score: 0.055
  26. Peptide presentation by bat MHC class I provides new insight into the antiviral immunity of bats. PLoS Biol. 2019 09; 17(9):e3000436.
    View in: PubMed
    Score: 0.053
  27. Salt bridge-forming residues positioned over viral peptides presented by MHC class I impacts T-cell recognition in a binding-dependent manner. Mol Immunol. 2019 08; 112:274-282.
    View in: PubMed
    Score: 0.052
  28. Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus. Nat Microbiol. 2019 07; 4(7):1231-1241.
    View in: PubMed
    Score: 0.051
  29. An Invariant Arginine in Common with MHC Class II Allows Extension at the C-Terminal End of Peptides Bound to Chicken MHC Class I. J Immunol. 2018 11 15; 201(10):3084-3095.
    View in: PubMed
    Score: 0.049
  30. Glycan Binding Specificity and Mechanism of Human and Porcine P[6]/P[19] Rotavirus VP8*s. J Virol. 2018 07 15; 92(14).
    View in: PubMed
    Score: 0.048
  31. Human Group C Rotavirus VP8*s Recognize Type A Histo-Blood Group Antigens as Ligands. J Virol. 2018 06 01; 92(11).
    View in: PubMed
    Score: 0.048
  32. Molecular basis of binding between the global post-transcriptional regulator CsrA and the T3SS chaperone CesT. Nat Commun. 2018 03 22; 9(1):1196.
    View in: PubMed
    Score: 0.048
  33. Two classes of protective antibodies against Pseudorabies virus variant glycoprotein B: Implications for vaccine design. PLoS Pathog. 2017 12; 13(12):e1006777.
    View in: PubMed
    Score: 0.047
  34. Crystal structure of the C-terminal fragment of NS1 protein from yellow fever virus. Sci China Life Sci. 2017 12; 60(12):1403-1406.
    View in: PubMed
    Score: 0.046
  35. An unexpected N-terminal loop in PD-1 dominates binding by nivolumab. Nat Commun. 2017 02 06; 8:14369.
    View in: PubMed
    Score: 0.044
  36. Protective T Cell Responses Featured by Concordant Recognition of Middle East Respiratory Syndrome Coronavirus-Derived CD8+ T Cell Epitopes and Host MHC. J Immunol. 2017 01 15; 198(2):873-882.
    View in: PubMed
    Score: 0.043
  37. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein. Cell Res. 2015 Nov; 25(11):1237-49.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.